Skip to Main content Skip to Navigation
Journal articles

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients

Olivier Bluteau 1, 2 Marie Sebert 2 Thierry Leblanc 3 Regis Peffault de Latour 4, 5, 6 Samuel Quentin 1 Elodie Lainey 7 Lucie Hernandez 2 Jean-Hugues Dalle 8 Flore Sicre de Fontbrune 5 Etienne Lengline 9 Raphaël Itzykson 2, 4 Emmanuelle Clappier 1, 2 Nicolas Boissel 4 Nadia Vasquez 1 Mélanie da Costa 1 Julien Masliah-Planchon 2 Wendy Cuccuini 1 Anna Raimbault 1, 2 Louis de Jaegere 2 Lionel Adès 9 Pierre Fenaux 9 Sébastien Maury 10 Claudine Schmitt 11, 12 Marc Muller 11, 12 Carine Domenech 13 Nicolas Blin 14 Bénédicte Bruno 15 Isabelle Pellier 16, 17 Mathilde Hunault-Berger 16, 17 Stéphane Blanche 18 Arnaud Petit 19 Guy Leverger 19 Gérard Michel 20, 21 Yves Bertrand 13 André Baruchel 4 Gérard Socié 5, 6 Jean Soulier 1, 2
16 CRCINA-ÉQUIPE 7 - Innate Immunity and Immunotherapy
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
Abstract : Bone marrow (BM) failure (BMF) in children and young adults is often suspected to be inherited, but in many cases diagnosis remains uncertain. We studied a cohort of 179 patients (from 173 families) with BMF of suspected inherited origin but unresolved diagnosis after medical evaluation and Fanconi anemia exclusion. All patients had cytopenias, and 12.0% presented ≥5% BM blast cells. Median age at genetic evaluation was 11 years; 20.7% of patients were aged ≤2 years and 36.9% were ≥18 years. We analyzed genomic DNA from skin fibroblasts using whole-exome sequencing, and were able to assign a causal or likely causal germ line mutation in 86 patients (48.0%), involving a total of 28 genes. These included genes in familial hematopoietic disorders (GATA2, RUNX1), telomeropathies (TERC, TERT, RTEL1), ribosome disorders (SBDS, DNAJC21, RPL5), and DNA repair deficiency (LIG4). Many patients had an atypical presentation, and the mutated gene was often not clinically suspected. We also found mutations in genes seldom reported in inherited BMF (IBMF), such as SAMD9 and SAMD9L (N = 16 of the 86 patients, 18.6%), MECOM/EVI1 (N = 6, 7.0%), and ERCC6L2 (N = 7, 8.1%), each of which was associated with a distinct natural history; SAMD9 and SAMD9L patients often experienced transient aplasia and monosomy 7, whereas MECOM patients presented early-onset severe aplastic anemia, and ERCC6L2 patients, mild pancytopenia with myelodysplasia. This study broadens the molecular and clinical portrait of IBMF syndromes and sheds light on newly recognized disease entities. Using a high-throughput sequencing screen to implement precision medicine at diagnosis can improve patient management and family counseling.
Document type :
Journal articles
Complete list of metadatas

Cited literature [53 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02909192
Contributor : Elizabeth Bernardo <>
Submitted on : Thursday, July 30, 2020 - 10:06:06 AM
Last modification on : Wednesday, October 14, 2020 - 4:12:30 AM
Long-term archiving on: : Tuesday, December 1, 2020 - 9:55:36 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

Olivier Bluteau, Marie Sebert, Thierry Leblanc, Regis Peffault de Latour, Samuel Quentin, et al.. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood, American Society of Hematology, 2018, 131 (7), pp.717-732. ⟨10.1182/blood-2017-09-806489⟩. ⟨inserm-02909192⟩

Share

Metrics

Record views

79